Selected research
Industry Research
Chitosan-based Hemostatic Gauze Industry Research Report 2026
Market perspective
The global Chitosan-based Hemostatic Gauze market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Chitosan-based Hemostatic Gauze is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Chitosan-based Hemostatic Gauze is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Chitosan-based Hemostatic Gauze is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Chitosan-based Hemostatic Gauze include Advamedica, Anscare, BioPharm Med, Hemoflex, MedTrade Products, Mermaid Medical, Tricol Biomedical, Biotemed and Shijiazhuang Yishengtang Medical Product, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Chitosan-based Hemostatic Gauze market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Chitosan-based Hemostatic Gauze Market by Company
Advamedica
Anscare
BioPharm Med
Hemoflex
MedTrade Products
Mermaid Medical
Tricol Biomedical
Biotemed
Shijiazhuang Yishengtang Medical Product
Chitosan-based Hemostatic Gauze Segment by Type
Z-shaped Folded Hemostatic Gauze
Non-folded Hemostatic Gauze
Chitosan-based Hemostatic Gauze Segment by Application
Surgery
First Aid
Chitosan-based Hemostatic Gauze Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chitosan-based Hemostatic Gauze market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Chitosan-based Hemostatic Gauze and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chitosan-based Hemostatic Gauze.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Chitosan-based Hemostatic Gauze manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Chitosan-based Hemostatic Gauze by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Chitosan-based Hemostatic Gauze in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Z-shaped Folded Hemostatic Gauze
- Non-folded Hemostatic Gauze
Applications
- Surgery
- First Aid
Companies covered
- Advamedica
- Anscare
- BioPharm Med
- Hemoflex
- MedTrade Products
- Mermaid Medical
- Tricol Biomedical
- Biotemed
- Shijiazhuang Yishengtang Medical Product
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Chitosan-based Hemostatic Gauze Market Size (2021-2032)
- 2.2.2 Global Chitosan-based Hemostatic Gauze Sales (2021-2032)
- 2.2.3 Global Chitosan-based Hemostatic Gauze Market Average Price (2021-2032)
- 2.3 Chitosan-based Hemostatic Gauze by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Z-shaped Folded Hemostatic Gauze
- 2.3.3 Non-folded Hemostatic Gauze
- 2.4 Chitosan-based Hemostatic Gauze by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Surgery
- 2.4.3 First Aid
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Chitosan-based Hemostatic Gauze Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Chitosan-based Hemostatic Gauze Sales (Units) of Manufacturers (2021-2026)
- 3.3 Global Chitosan-based Hemostatic Gauze Revenue of Manufacturers (2021-2026)
- 3.4 Global Chitosan-based Hemostatic Gauze Average Price by Manufacturers (2021-2026)
- 3.5 Global Chitosan-based Hemostatic Gauze Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Chitosan-based Hemostatic Gauze, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Chitosan-based Hemostatic Gauze, Product Type & Application
- 3.8 Global Manufacturers of Chitosan-based Hemostatic Gauze, Established Date
- 3.9 Global Chitosan-based Hemostatic Gauze Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Advamedica
- 4.1.1 Advamedica Company Information
- 4.1.2 Advamedica Business Overview
- 4.1.3 Advamedica Chitosan-based Hemostatic Gauze Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Advamedica Chitosan-based Hemostatic Gauze Product Portfolio
- 4.1.5 Advamedica Recent Developments
- 4.2 Anscare
- 4.2.1 Anscare Company Information
- 4.2.2 Anscare Business Overview
- 4.2.3 Anscare Chitosan-based Hemostatic Gauze Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Anscare Chitosan-based Hemostatic Gauze Product Portfolio
- 4.2.5 Anscare Recent Developments
- 4.3 BioPharm Med
- 4.3.1 BioPharm Med Company Information
- 4.3.2 BioPharm Med Business Overview
- 4.3.3 BioPharm Med Chitosan-based Hemostatic Gauze Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 BioPharm Med Chitosan-based Hemostatic Gauze Product Portfolio
- 4.3.5 BioPharm Med Recent Developments
- 4.4 Hemoflex
- 4.4.1 Hemoflex Company Information
- 4.4.2 Hemoflex Business Overview
- 4.4.3 Hemoflex Chitosan-based Hemostatic Gauze Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Hemoflex Chitosan-based Hemostatic Gauze Product Portfolio
- 4.4.5 Hemoflex Recent Developments
- 4.5 MedTrade Products
- 4.5.1 MedTrade Products Company Information
- 4.5.2 MedTrade Products Business Overview
- 4.5.3 MedTrade Products Chitosan-based Hemostatic Gauze Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 MedTrade Products Chitosan-based Hemostatic Gauze Product Portfolio
- 4.5.5 MedTrade Products Recent Developments
- 4.6 Mermaid Medical
- 4.6.1 Mermaid Medical Company Information
- 4.6.2 Mermaid Medical Business Overview
- 4.6.3 Mermaid Medical Chitosan-based Hemostatic Gauze Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Mermaid Medical Chitosan-based Hemostatic Gauze Product Portfolio
- 4.6.5 Mermaid Medical Recent Developments
- 4.7 Tricol Biomedical
- 4.7.1 Tricol Biomedical Company Information
- 4.7.2 Tricol Biomedical Business Overview
- 4.7.3 Tricol Biomedical Chitosan-based Hemostatic Gauze Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Tricol Biomedical Chitosan-based Hemostatic Gauze Product Portfolio
- 4.7.5 Tricol Biomedical Recent Developments
- 4.8 Biotemed
- 4.8.1 Biotemed Company Information
- 4.8.2 Biotemed Business Overview
- 4.8.3 Biotemed Chitosan-based Hemostatic Gauze Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Biotemed Chitosan-based Hemostatic Gauze Product Portfolio
- 4.8.5 Biotemed Recent Developments
- 4.9 Shijiazhuang Yishengtang Medical Product
- 4.9.1 Shijiazhuang Yishengtang Medical Product Company Information
- 4.9.2 Shijiazhuang Yishengtang Medical Product Business Overview
- 4.9.3 Shijiazhuang Yishengtang Medical Product Chitosan-based Hemostatic Gauze Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Shijiazhuang Yishengtang Medical Product Chitosan-based Hemostatic Gauze Product Portfolio
- 4.9.5 Shijiazhuang Yishengtang Medical Product Recent Developments
5 Global Chitosan-based Hemostatic Gauze Market Scenario by Region
- 5.1 Global Chitosan-based Hemostatic Gauze Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Chitosan-based Hemostatic Gauze Sales by Region: 2021-2032
- 5.2.1 Global Chitosan-based Hemostatic Gauze Sales by Region: 2021-2026
- 5.2.2 Global Chitosan-based Hemostatic Gauze Sales by Region: 2027-2032
- 5.3 Global Chitosan-based Hemostatic Gauze Revenue by Region: 2021-2032
- 5.3.1 Global Chitosan-based Hemostatic Gauze Revenue by Region: 2021-2026
- 5.3.2 Global Chitosan-based Hemostatic Gauze Revenue by Region: 2027-2032
- 5.4 North America Chitosan-based Hemostatic Gauze Market Facts & Figures by Country
- 5.4.1 North America Chitosan-based Hemostatic Gauze Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Chitosan-based Hemostatic Gauze Sales by Country (2021-2032)
- 5.4.3 North America Chitosan-based Hemostatic Gauze Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Chitosan-based Hemostatic Gauze Market Facts & Figures by Country
- 5.5.1 Europe Chitosan-based Hemostatic Gauze Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Chitosan-based Hemostatic Gauze Sales by Country (2021-2032)
- 5.5.3 Europe Chitosan-based Hemostatic Gauze Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Chitosan-based Hemostatic Gauze Market Facts & Figures by Country
- 5.6.1 Asia Pacific Chitosan-based Hemostatic Gauze Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Chitosan-based Hemostatic Gauze Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Chitosan-based Hemostatic Gauze Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Chitosan-based Hemostatic Gauze Market Facts & Figures by Country
- 5.7.1 South America Chitosan-based Hemostatic Gauze Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Chitosan-based Hemostatic Gauze Sales by Country (2021-2032)
- 5.7.3 South America Chitosan-based Hemostatic Gauze Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Chitosan-based Hemostatic Gauze Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Chitosan-based Hemostatic Gauze Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Chitosan-based Hemostatic Gauze Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Chitosan-based Hemostatic Gauze Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Chitosan-based Hemostatic Gauze Sales by Type (2021-2032)
- 6.1.1 Global Chitosan-based Hemostatic Gauze Sales by Type (2021-2032) & (Units)
- 6.1.2 Global Chitosan-based Hemostatic Gauze Sales Market Share by Type (2021-2032)
- 6.2 Global Chitosan-based Hemostatic Gauze Revenue by Type (2021-2032)
- 6.2.1 Global Chitosan-based Hemostatic Gauze Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Chitosan-based Hemostatic Gauze Revenue Market Share by Type (2021-2032)
- 6.3 Global Chitosan-based Hemostatic Gauze Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Chitosan-based Hemostatic Gauze Sales by Application (2021-2032)
- 7.1.1 Global Chitosan-based Hemostatic Gauze Sales by Application (2021-2032) & (Units)
- 7.1.2 Global Chitosan-based Hemostatic Gauze Sales Market Share by Application (2021-2032)
- 7.2 Global Chitosan-based Hemostatic Gauze Revenue by Application (2021-2032)
- 7.2.1 Global Chitosan-based Hemostatic Gauze Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Chitosan-based Hemostatic Gauze Revenue Market Share by Application (2021-2032)
- 7.3 Global Chitosan-based Hemostatic Gauze Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Chitosan-based Hemostatic Gauze Value Chain Analysis
- 8.1.1 Chitosan-based Hemostatic Gauze Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Chitosan-based Hemostatic Gauze Production Mode & Process
- 8.2 Chitosan-based Hemostatic Gauze Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Chitosan-based Hemostatic Gauze Distributors
- 8.2.3 Chitosan-based Hemostatic Gauze Customers
9 Global Chitosan-based Hemostatic Gauze Analyzing Market Dynamics
- 9.1 Chitosan-based Hemostatic Gauze Industry Trends
- 9.2 Chitosan-based Hemostatic Gauze Industry Drivers
- 9.3 Chitosan-based Hemostatic Gauze Industry Opportunities and Challenges
- 9.4 Chitosan-based Hemostatic Gauze Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst